Pure Global

Pre-operative Immuno-Nutrition in Radical Cystectomy - Trial NCT06355518

Access comprehensive clinical trial information for NCT06355518 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia and is currently Not yet recruiting. The study focuses on Bladder Cancer. Target enrollment is 260 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06355518
Not yet recruiting
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT06355518
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Pre-operative Immuno-Nutrition in Radical Cystectomy
Pre-operative Immuno-nutrition in Patients Undergoing Radical Cystectomy for Bladder Cancer: a Multicentre, Randomised, Open-label, Parallel Group Study

Study Focus

Bladder Cancer

Immunonutrition

Interventional

dietary supplement

Sponsor & Location

Fondazione IRCCS Policlinico San Matteo di Pavia

Milan,Pavia, Italy

Timeline & Enrollment

N/A

Apr 01, 2024

Sep 01, 2026

260 participants

Primary Outcome

30-day complications

Summary

This study will evaluate the effect of preoperative oral immunonutrition on postoperative
 complications in patients undergoing radical cystectomy for bladder cancer. Patients
 receiving preoperative immunonutrition will be compared to controls receiving a standard
 high-calorie, high-protein oral nutritional supplement.

ICD-10 Classifications

Malignant neoplasm of bladder
Malignant neoplasm: Bladder, unspecified
Malignant neoplasm: Dome of bladder
Malignant neoplasm: Overlapping lesion of bladder
Malignant neoplasm: Lateral wall of bladder

Data Source

ClinicalTrials.gov

NCT06355518

Non-Device Trial